Affinity Asset Advisors »

Macrogenics shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Macrogenics (MGNX) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Macrogenics

Tip: Access up to 7 years of quarterly data

All positions including Macrogenics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Macrogenics by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $780k 484k 1.61
2021-06-30 $2.1M 80k 26.86
2021-03-31 $796k 25k 31.84

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding Macrogenics

Armistice Capital
Vanguard Group
Frazier Life Sciences Management
Renaissance Technologies
Acadian Asset Management
Millennium Management
Leucadia National Corporation
Daniel D. Thurber
BlackRock
Marshall Wace
Jane Street
Jacobs Levy Equity Management
Connor, Clark & Lunn Investment Management
Jpmorgan Chase & Co
Two Sigma Advisers

View all funds holding Macrogenics